Dr Fernando Fonseca Guimaraes leads the Translational innate immunotherapy group.

 

Researcher biography

In 2012, I achieved a significant milestone by becoming the first student to complete a doctoral degree from the prestigious International PhD Program at Institute Pasteur, Paris/France. This accomplishment not only set the trajectory of my academic pursuits but also underscored my dedication and passion for research in immunology.

My dedication to my field has been recognized through numerous peer-reviwed grants as sole-CI or CIA/Principal Investigator, including a NHMRC ECF Peter Doherty Fellowship, an NHMRC Project Grant, an US DoD, a MRFF among others. Since 2009, I've amassed an impressive portfolio of 90 publications in renowned journals like Blood, Cell Death Dis, JEM, PNAS, Nat Comms, and Nat Immunol with an H-index = 39. My body of work and contributions have been acknowledged with awards such as the 2019 Researcher of the Year by CCA, 2020 QLD Young Tall Poppy Science Award, 2020 UQDI Rising Star Award, the 2022 Frazer Institute's Mentor of the Year Award among others. Recognized as an international leader in my field, I've been instrumental in identifying novel regulators of our immune functions, and developing Natural Killer (NK) cell-based immunotherapies.

At present, I am a Group Leader / Principal Research Fellow & Associate Professor with the University of Queensland's Frazer Institute. Here, I lead a high-performing research team with a keen focus on developing and innovating immunotherapy approaches for a spectrum of diseases.